Lingabrique
Lingabrique
Active Ingredients:
90 mg ticagrelor Oro-dispersible Tablets
Indications
Lingabrique, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with:
- acute coronary syndromes (ACS) or
- a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event.